Skip to content
Open access

Mechanistic Insights into Aldose Reductase-Dependent Modulation of Hypoxia-Inducible Factor-1α in Promoting Renal Fibrosis

Aug 2026 · Cell Biochemistry and Biophysics · Vol 84, pp. 4599 - 4611 · 0 citations · 47 references
Medicine

TL;DR

In the in vitro study, knockdown of AR through siRNA or pharmacological inhibition markedly reduced transforming growth factor-beta 1 (TGF-β1)-induced HIF-1α expression, inhibited PI3K/AKT pathway activation, restored mitochondrial autophagy function, and reversed EMT in RTECs.

Abstract

Renal fibrosis (RF) represents the common pathological endpoint of all chronic kidney diseases. According to recent evidence, impaired mitophagy, which facilitates epithelial-mesenchymal transition (EMT) in renal tubular epithelial cells (RTECs), substantially contributes to RF progression, although the underlying mechanisms remain unclear. We previously demonstrated that mitophagy mediated by aldose reductase (AR) promotes EMT of hepatocytes. Further investigations are warranted to elucidate whether AR affects RF and EMT in RTECs through the regulation of impaired mitophagy. In the in vivo study, AR knockout remarkably reduced Phosphoinositide 3-kinase (PI3K) and serine/threonine kinase (AKT) phosphorylation and attenuated hypoxia-inducible factor-1α (HIF-1α) expression, while increasing Pink1 and Parkin expression in unilateral ureteral obstruction (UUO)-exposed renal tissues. These changes were linked with a higher expression ratio of microtubule-associated protein 1 light chain 3 (LC3) II/I; low p62 expression; decreased Snail, α-smooth muscle actin (α-SMA), and vimentin expression; enhanced E-cadherin expression; and a reduction in mitochondrial damage, which collectively contributed to mitigate RF. In the in vitro study, knockdown of AR through siRNA or pharmacological inhibition markedly reduced transforming growth factor-beta 1 (TGF-β1)-induced HIF-1α expression, inhibited PI3K/AKT pathway activation, restored mitochondrial autophagy function, decreased levels of reactive oxygen species (ROS) and mitochondrial permeability transition pore (MPTP) opening, and increased mitochondrial membrane potential (ΔΨm) and adenosine triphosphate (ATP) production, thereby reversing EMT in RTECs. Conversely, AR overexpression exacerbated TGF-β1-induced HIF-1α expression, enhanced PI3K/AKT pathway activation, lowered efficiency of mitophagy, increased MPTP opening and ROS levels, reduced ΔΨm and ATP production, and promoted EMT. These findings highlight AR’s role as a facilitator of EMT in RTECs and emphasize its critical contribution to RF progression. This process may be mediated by AR-induced expression of HIF-1α, which stimulates the PI3K/AKT signaling pathway, leading to inhibition of Pink1 and Parkin expression, ultimately decreasing mitophagy occurrence in RTECs.

Read PDF

Similar papers

Aug 2026

The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension.

OBJECTIVE Pulmonary hypertension (PH) involves endothelial-to-mesenchymal transition (EndMT) in vascular remodeling. Rosiglitazone (RSG), a peroxisome proliferator-activated receptor gamma agonist, alleviates PH, but its direct effect on EndMT is unclear. The study explores RSG's role and mechanism in inhibiting EndMT....

Ao-Xue Yuan, Yaqian Bai, Yuanhang Jiang et al. · 0 citations
Sep 2026

SDHB deficiency promotes renal fibrosis by triggering mtRNA leakage and activating the RIG-I-MAVS pathway.

It is demonstrated that SDHB is down-regulated in fibrotic kidneys, and mechanistic insights into how TCA cycle disruptions and mtRNA leakage interactions drive renal inflammation are provided, suggesting SDHB as a potential therapeutic target for renal fibrosis.

Zi-Jing Zhu, Ping Chen, Hong-Xin Shu et al. · 0 citations
Sep 2026

A Non-canonical role of phloretin in renal protection: Targeting WNT2B downregulation to prime PINK1/ PARKIN-dependent mitophagy and attenuate renal fibrosis.

Renal fibrosis, the common pathological endpoint of diverse kidney injuries, drives the progression to end-stage kidney disease. Its rising prevalence, mirroring the global chronic kidney disease burden, starkly contrasts with the unmet need for safe and effective therapies. Fibrogenesis is centrally driven by transfor...

Xue Wu, Yong-Hui Dong, Jia Li et al. · 0 citations
Open access Sep 2026

PCSK9 Inhibition Attenuates Renal Oxidative Stress and Lipotoxicity in Diabetic Kidney Disease in Association with AMPK Activation

Renal lipotoxicity and oxidative stress are major contributors to diabetic kidney disease (DKD), but the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) and its relationship with AMP-activated protein kinase (AMPK) signaling remain unclear. We investigated the effects of PCSK9 inhibition on renal lipotoxi...

Keum-Jin Yang, Sun-Ha Lee, Sungmi Kim et al. · 0 citations
Open access Aug 2026

A self-sustaining hypoxia inducible factor-1α-creatine kinase B feedforward circuit drives macrophage-mediated kidney fibrosis.

INTRODUCTION A fundamental challenge in treating chronic kidney disease (CKD) is the lack of therapies to reverse established fibrosis. While systemic hypoxia sensors like erythrocyte sphingosine kinase 1 (eSPHK1) can initiate fibrotic signaling, the mechanisms driving self-perpetuating and progressive fibrosis remain...

Tingting Xie, Hao Qi, Piaoyu Dai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.